| Literature DB >> 33065292 |
Han Zhang1, Siqi Zhao1, Jie Yu1, Wei Yang2, Zhenming Liu3, Liangren Zhang4.
Abstract
Transient receptor potential melastatin 2 (TRPM2) is a Ca2+- permeable nonselective cation channel that is involved in diverse biological functions as a cellular sensor for oxidative stress and temperature. It has been considered a promising therapeutic target for the treatment of ischemia/reperfusion (IR) injury, inflammation, cancer, and neurodegenerative diseases. Development of highly potent and selective TRPM2 inhibitors and validation of their use in relevant disease models will advance drug discovery. In this review, we describe the molecular structures and gating mechanism of the TRPM2 channel, and offer a comprehensive review of advances in the discovery of TRPM2 inhibitors. Furthermore, we analyze the properties of reported TRPM2 inhibitors with an emphasis on how specific inhibitors targeting this channel could be better developed.Entities:
Year: 2020 PMID: 33065292 DOI: 10.1016/j.drudis.2020.09.039
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851